Minapharm Pharmaceuticals (Minapharm) reported a 184% Year on Year increase in its consolidated net profit in the first nine months
By Staff Writer, Arab Finance
ArabFinance:Minapharm Pharmaceuticals (Minapharm) reported a 184% Year on Year increase in its consolidated net profit in the first nine months of 2020, according to the company’s November 29th financial statements filed to the Egyptian Exchange.
Consolidated net profit before minority interest stood at EGP 201,131,077 in the January-September 2020, compared to EGP 70,923,877 achieved in the prior-year period.
On May 25th, the company's ordinary general meeting approved the distribution of a total of EGP 73,760,640 worth of dividends.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW